Ko-Med Centra Kliniczne Sp. z o.o.

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Stroke2 trials
• Atrial fibrillation1 trial
• Coronary artery disease1 trial
• Rheumatoid arthritis1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Completed3 trials

Lead sponsor

• Amgen1 trial
• Bayer AG1 trial
• Immunemed Inc.1 trial

Closed trials

• Completed

  A Phase 2a multi-center, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of Burfiralimab (hzVSF-v13) added to disease-modifying antirheumatic drugs in patient with moderate to severe Rheumatoid Arthritis

  2023-507944-35-00· Phase 2· Immunemed Inc.· Source

• Completed

  A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolism in people with irregular and often rapid heartbeat (atrial fibrillation), and at risk for stroke

  NCT05643573· Phase 3· Bayer AG· Source

• Completed

  Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

  NCT03872401· Phase 3· Amgen· Source